ASH Annual Meeting

ASH Annual Meeting

Interviews from the American Society of Hematology’s Annual Meeting

Deepu Madduri: Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

Deepu Madduri, MD, discusses data from the phase Ib/II CARTITUDE-1 study evaluating chimeric antigen receptor (CAR) T cell therapy ciltacabtagene autoleucel in patients with...

Steven Pipe: Etranacogene Dezaparvovec Gene Therapy for Hemophilia B

Steven Pipe, MD, shares safety and efficacy data from a phase III study of etranacogene dezaparvovec gene therapy in patients with hemophilia B.

Charlotte Bradbury: Adding Mycophenolate to Corticosteroid for ITP

Mycophenolate alongside corticosteroids may be considered as an effective first-line treatment option for some patients with immune thrombocytopenia. Charlotte Bradbury, MD, discusses results from...

José Blanco: Accessory Splenectomy in Patients with Immune Cytopenias

José Blanco, MD, discusses whether searching for an accessory spleen or performing accessory splenectomy is a safe and effective treatment for patients with refractory...

Anthony Mato: LOXO-305 Demonstrates Efficacy in Patients With CLL/SLL

Anthony Mato, MD, shares findings from a phase I/II trial evaluating LOXO-305 in patients with heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Tippi MacKenzie: In Utero Hematopoietic Cell Transplantation for Hematologic Conditions

In utero hematopoietic cell transplantation showed promise in a phase 1 clinical trial involving fetuses with alpha thalassemia major. Here, Tippi Mackenzie, MD, discusses...

Amy Shapiro: SIG-001 Cell Therapy for Hemophilia A

Amy Shapiro, MD, discusses results from a first-in-human phase I/II trial assessing SIG-001 in patients with hemophilia A.

Simon Harrison: Early Data on AMG 701 for Heavily Pretreated Relapsed/Refractory Multiple Myeloma

Simon Harrison, MBBS, PhD, shares results from a phase I first-in-human trial evaluating AMG 701, an anti‑BCMA BiTE® molecule, in patients with heavily pre‑treated...

Andreas Hochhaus: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia

Andreas Hochhaus, MD, discusses results from a phase I study suggesting asciminib may have superior efficacy to bosutinib in patients with heavily pretreated chronic...

Nichola Cooper: Fostamatinib in Warm Antibody Autoimmune Hemolytic Anemia

Patients with warm antibody autoimmune hemolytic anemia (wAIHA) had markedly improved hemoglobin levels after fostamatinib treatment. Here, Nichola Cooper, MD, shares results from a phase...
Advertisement

Current Issue

July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9

This issue features conversations with ASH Clinical Research Training Institute graduates, highlights from the virtual ASCO and EHA annual meetings, and more.

Block title